Literature DB >> 11845539

Acute ischemic syndromes. Chest pain center concept.

Ezra A Amsterdam1, William R Lewis, J Douglas Kirk, Deborah B Diercks, Samuel Turnipseed.   

Abstract

CPCs have been developed to meet the clinical challenge posed by the diverse group of patients presenting to the ED with findings suggestive of a coronary event. Using a protocol-driven approach, high- and low-risk patients can be identified on presentation, facilitating urgent therapy in the former and triage of the latter to more deliberate management. Most CPCs focus on low-risk patients who are being increasingly managed by accelerated diagnostic protocols. These methods comprise systematic strategies that include innovative diagnostic approaches during a 6 to 12 hour period of observation with serial ECGs, continuous monitoring and cardiac biomarker measurements. A negative evaluation is usually followed by predischarge stress testing, and positive findings mandate admission. An essential aspect of the CPC strategy is continuity of care for patients with negative cardiac evaluations. Current data indicate that management of low-risk patients with chest pain in a CPC is safe accurate, and appears to be cost-effective.

Entities:  

Mesh:

Year:  2002        PMID: 11845539     DOI: 10.1016/s0733-8651(03)00069-9

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  2 in total

Review 1.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association.

Authors:  Ezra A Amsterdam; J Douglas Kirk; David A Bluemke; Deborah Diercks; Michael E Farkouh; J Lee Garvey; Michael C Kontos; James McCord; Todd D Miller; Anthony Morise; L Kristin Newby; Frederick L Ruberg; Kristine Anne Scordo; Paul D Thompson
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

2.  Improved outcome in acute coronary syndrome by establishing a chest pain unit.

Authors:  Till Keller; Felix Post; Stergios Tzikas; Astrid Schneider; Sven Arnolds; Oliver Scheiba; Stefan Blankenberg; Thomas Münzel; Sabine Genth-Zotz
Journal:  Clin Res Cardiol       Date:  2009-12-24       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.